Search
for
Sort by
Research 451–480 of 1000+
- Alopecia Universalis Occurring after Alemtuzumab Treatment for Multiple Sclerosis. A Two-Year Follow-Up of Two Patients
- Gene Expression of CD70 and CD27 Is Increased in Alopecia Areata Lesions and Associated with Disease Severity and Activity
- CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico
- Immune therapies for alopecia areata: evidence and new perspectives
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Frontal fibrosing alopecia preceding the development of vitiligo: A case report
- A Case of Vitiligo Combined with Systemic Lupus Erythematosus Treated with Tofacitinib
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- New Modalities in the Treatment of Refractory Alopecia Areata
- Early Hair Regrowth With Adjunctive Secretome Therapy in Severe Patchy Alopecia Areata
- Metabolic and Vascular Inflammation in Alopecia Areata: Linking Uric Acid, Lipid Imbalance and ICAM ‐1 Upregulation
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Interleukin-10-deficient Mice Are Less Susceptible to the Induction of Alopecia Areata
- Dermatological complications due to post‑COVID‑19 syndrome: A systematic review
- Frontal fibrosing alopecia: A review of disease pathogenesis
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Squaric Acid Dibutylester Promotes Innate Immune-Driven Hair Growth with CD206+ Macrophage Accumulation in the Dermis
- Platelet-Rich Concentrates in the Management of Lichen Planus—A Comprehensive Review
- Clinical Snippets
- Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA)
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- Ritlecitinib for the Management of Alopecia Areata: A Narrative Review of Real-World Evidence and Selected Post Hoc Analyses
- Immunopathogenesis and Experimental Models of Alopecia Areata: From Mechanistic Insights to Translational Platforms